Fibronectin and Laminin: The Tissue Glue Peptides
Structural Peptides
RGD tripeptide
The three-amino-acid sequence arginine-glycine-aspartate (RGD) in fibronectin is the most widely used cell-adhesion motif in biomedical engineering, binding over 20 different integrin receptors.
Sivaraman et al., Life Sciences, 2018
Sivaraman et al., Life Sciences, 2018
View as imageCollagen gets most of the attention in the peptide world, but it does not work alone. Two other glycoproteins, fibronectin and laminin, are equally essential to the physical integrity of human tissue. Fibronectin connects cells to the collagen scaffold in connective tissue. Laminin anchors epithelial cells to the basement membrane beneath skin, blood vessels, and organs. Without either protein, tissues lose their structural organization and cells lose the signals they need to survive, divide, and repair damage. Both proteins contain short peptide sequences, most famously RGD from fibronectin and YIGSR from laminin, that have become foundational tools in tissue engineering, wound healing research, and cosmetic science.[1] For how these proteins relate to other structural components of skin, see our pillar article on elastin peptides and aging skin.
Key Takeaways
- Fibronectin is a 440 kDa dimeric glycoprotein that acts as a bridge between cell surface integrins and the collagen/proteoglycan matrix, organizing extracellular matrix assembly
- Laminin is a heterotrimeric protein (400-900 kDa) that forms the structural foundation of basement membranes, with 16+ isoforms identified in humans
- The RGD (arginine-glycine-aspartate) tripeptide from fibronectin is the most widely used cell-adhesion motif in biomedicine, recognized by over 20 integrin receptor subtypes (Sivaraman et al., 2018)
- The YIGSR pentapeptide from laminin's beta-1 chain promotes endothelial cell adhesion and has been used in vascular graft engineering
- Both proteins generate bioactive fragments called matrikines when degraded by matrix metalloproteinases, which signal surrounding cells to initiate repair (Sirois et al., 2024)
- Synthetic fibronectin and laminin peptide fragments are used in tissue engineering scaffolds, wound dressings, and cosmetic formulations targeting cell adhesion and migration
What fibronectin does in the body
Fibronectin exists in two forms. Plasma fibronectin circulates in blood at concentrations of approximately 300 mcg/mL and is produced primarily by hepatocytes. Cellular fibronectin is assembled into insoluble fibrils by fibroblasts and other cells directly within tissues. Both forms share the same gene (FN1) but differ through alternative splicing of three domains: EDA, EDB, and the IIICS region.
The protein is a dimer of approximately 440 kDa, with two nearly identical subunits linked by disulfide bonds near the C-terminus. Each subunit contains a linear array of roughly 30 modular domains organized into three types (FN-I, FN-II, FN-III), which create binding sites for collagen, fibrin, heparan sulfate proteoglycans, and cell surface integrins.
Fibronectin's central function is bridging. It connects cells to their surrounding matrix by simultaneously binding integrins on the cell surface and collagen, fibrin, or other matrix components on the extracellular side. This bridging function is why fibronectin is sometimes called the "master organizer" of extracellular matrix assembly: without fibronectin fibrils, collagen fibrils do not organize properly, and the matrix fails to form a functional scaffold.[2]
The integrin-binding function depends on a specific tripeptide sequence: arginine-glycine-aspartate, or RGD. This three-amino-acid motif, located in the 10th type III repeat of fibronectin, is recognized by at least eight different integrin heterodimers, including alpha-5-beta-1 (the "fibronectin receptor") and alpha-v-beta-3. A second synergy site (PHSRN) located in the adjacent 9th type III repeat enhances integrin binding specificity and affinity.
What laminin does in the body
Laminin is the primary structural glycoprotein of basement membranes, the thin sheets of specialized extracellular matrix that underlie all epithelial and endothelial cell layers and surround muscle cells, fat cells, and Schwann cells in peripheral nerves.
Each laminin molecule is a heterotrimer composed of one alpha, one beta, and one gamma chain. Humans express five alpha chains, four beta chains, and three gamma chains, which combine to form at least 16 known laminin isoforms. The naming convention reflects the chain composition: laminin-332 (formerly laminin-5) contains alpha-3, beta-3, and gamma-2 chains and is the dominant laminin in the skin basement membrane.
Laminins self-polymerize into sheet-like networks that provide the architectural foundation of basement membranes. They also bind to type IV collagen networks, nidogen (entactin), and perlecan (a heparan sulfate proteoglycan), creating a dense, molecularly organized barrier between epithelial and connective tissue compartments.
Like fibronectin, laminin binds to integrins on cell surfaces, but it also interacts with non-integrin receptors including dystroglycan (critical in muscle) and Lutheran blood group glycoprotein. The key laminin-derived adhesion peptide is YIGSR (tyrosine-isoleucine-glycine-serine-arginine), located on the beta-1 chain. A second bioactive sequence, IKVAV (isoleucine-lysine-valine-alanine-valine), located on the alpha-1 chain, promotes neurite outgrowth and is studied in neural tissue engineering.
The matrikine concept: when fragments become signals
When fibronectin and laminin are degraded by matrix metalloproteinases (MMPs) during tissue remodeling, wound healing, or aging, the resulting peptide fragments do not simply disappear. Many of these fragments have biological activities distinct from the parent protein. These bioactive fragments are called matrikines.[3]
Sirois et al. (2024) reviewed the expanding landscape of matrikines identified from extracellular matrix proteins, documenting how fragments from fibronectin, laminin, collagen, elastin, and other matrix components act as signaling molecules that modulate cell behavior, angiogenesis, inflammation, and tissue repair.[3]
The concept was pioneered by Maquart et al., who demonstrated in 1988 that specific peptide sequences from extracellular matrix proteins could stimulate collagen synthesis in fibroblast cultures.[4] Their subsequent 1993 study confirmed that these matrix-derived peptides could stimulate collagen and glycosaminoglycan production in vivo, establishing that matrikines have biological activity beyond cell culture systems.[5]
Sivaraman et al. (2018) catalogued the matrikine landscape for therapeutic and biomedical applications, identifying peptide fragments from collagen (PGP tripeptide, endostatin), fibronectin (Anastellin, RGD-containing fragments), laminin (AG73, YIGSR, IKVAV), and elastin (VGVAPG) as having documented biological activities ranging from wound healing promotion to anti-tumor effects.[1]
This matrikine biology has direct implications for cosmetic peptide science. Signal peptides like Matrixyl (palmitoyl-KTTKS) are synthetic matrikines, fragments of type I procollagen that stimulate fibroblast collagen production when applied topically.[6]
RGD: the universal adhesion peptide
The RGD sequence is the single most important peptide motif in cell adhesion biology. Discovered in fibronectin in the 1980s, it has since been found in vitronectin, fibrinogen, von Willebrand factor, osteopontin, bone sialoprotein, and several other extracellular matrix proteins. Over 20 integrin receptor subtypes recognize some form of the RGD sequence.[1]
In tissue engineering, RGD peptides are grafted onto synthetic polymer scaffolds, hydrogels, and nanofibers to promote cell attachment. A scaffold made of polyethylene glycol or polylactic acid is biologically inert: cells cannot adhere to it. Coating the scaffold with RGD peptides transforms it into a surface that cells recognize and attach to, enabling tissue regeneration.
Chau et al. (2008) demonstrated that incorporating matrix metalloproteinase-sensitive peptide sequences alongside RGD into hydrogel scaffolds created materials that cells could both adhere to and remodel, mimicking the dynamic behavior of natural extracellular matrix.[7]
Anderson et al. (2011) developed biphasic peptide amphiphile nanomatrix gels containing both RGD and IKVAV (the laminin-derived neurite growth sequence), demonstrating that combining adhesion peptides from different matrix proteins can create scaffolds with multiple biological functions.[2]
The clinical applications of RGD peptides extend beyond tissue engineering. Cyclic RGD peptides (like cilengitide) have been tested as integrin antagonists in cancer therapy, aiming to block tumor angiogenesis by preventing endothelial cell adhesion to the tumor vasculature matrix. RGD-conjugated radiotracers are used in PET imaging to visualize integrin expression in tumors and atherosclerotic plaques.
YIGSR and IKVAV: laminin's bioactive fragments
Laminin contributes two major bioactive peptide sequences to the tissue engineering and biomedical toolkit.
YIGSR (from the laminin beta-1 chain) promotes cell adhesion, particularly of endothelial cells. It binds to the 67 kDa laminin receptor on cell surfaces. In vascular tissue engineering, YIGSR-coated synthetic grafts promote endothelial cell attachment and reduce thrombogenicity. YIGSR has also been studied as an anti-metastatic peptide: by competing with tumor cells for laminin receptor binding, it can inhibit basement membrane attachment and invasion in experimental models.
IKVAV (from the laminin alpha-1 chain) selectively promotes neurite outgrowth from neural cells. It activates signaling pathways involved in neuronal differentiation and has been incorporated into injectable hydrogels and electrospun nanofibers for spinal cord injury repair and peripheral nerve regeneration. IKVAV does not promote adhesion of all cell types equally; its selectivity for neural cells makes it valuable for designing scaffolds that guide specific tissue regeneration.
The selectivity of these sequences is important. RGD promotes adhesion broadly across cell types. YIGSR is preferential for endothelial cells. IKVAV is selective for neurons. Tissue engineers exploit these differences to build scaffolds that attract specific cell populations to specific locations within a construct.
Fibronectin and laminin in wound healing
Wound healing depends on fibronectin and laminin at every stage.
In the inflammatory phase (hours to days after injury), plasma fibronectin accumulates in the wound clot alongside fibrin, creating a provisional matrix. This fibronectin-fibrin matrix provides the adhesive substrate that neutrophils and macrophages crawl along to reach the wound site. Without fibronectin, immune cell migration into the wound is impaired.
In the proliferative phase (days to weeks), cellular fibronectin produced by fibroblasts guides the deposition of new collagen. Fibroblasts use fibronectin fibrils as a template for organizing collagen fiber alignment. Simultaneously, keratinocytes migrating across the wound surface use fibronectin and laminin fragments as directional cues.
In the remodeling phase (weeks to months), the provisional fibronectin matrix is gradually replaced by mature collagen. Laminin is re-deposited at the dermal-epidermal junction as the basement membrane reforms, re-establishing the barrier between epidermis and dermis. The quality of this basement membrane reformation determines scar appearance and skin function.
Research into peptide-based wound dressings is applying this biology directly: incorporating fibronectin-derived RGD peptides and laminin-derived YIGSR into dressing materials to accelerate cell adhesion and migration at the wound surface.
Fibronectin and laminin in cosmetic science
The cosmetic peptide industry has borrowed heavily from fibronectin and laminin biology, though the connection is rarely made explicit on product labels.
Signal peptides in skincare products work by mimicking the matrikine fragments of extracellular matrix proteins, including fibronectin and laminin. When these peptides reach fibroblasts, they trigger the same collagen synthesis response that natural matrix degradation products produce.[6] GHK-Cu, one of the most studied cosmetic peptides, stimulates fibroblast production of both collagen and fibronectin, increasing the overall density of the dermal matrix.
The connection to laminin is less direct in commercial products. Laminin production by keratinocytes is essential for basement membrane integrity, and age-related thinning of the basement membrane contributes to the fragile, translucent appearance of aged skin. Peptides that stimulate laminin production are a theoretical target for anti-aging formulations, but fewer commercial products specifically claim laminin upregulation compared to collagen stimulation. Keratin peptides for hair and nails represent another branch of structural protein supplementation that shares some biological overlap with the fibronectin and laminin story.
For the broader evidence base on whether these peptides produce visible results when applied topically, see do peptide serums actually work.
Genetic disorders reveal what happens without them
The importance of fibronectin and laminin becomes most visible when they are absent or defective.
Laminin deficiencies cause devastating diseases. Mutations in the LAMA2 gene (laminin alpha-2 chain) cause merosin-deficient congenital muscular dystrophy (MDC1A), characterized by severe muscle weakness from birth and white matter abnormalities in the brain. Mutations in LAMA3, LAMB3, or LAMC2 (the chains of laminin-332) cause junctional epidermolysis bullosa, a blistering skin disease where the epidermis separates from the dermis at the basement membrane because cells cannot anchor to a defective laminin network.
Fibronectin knockout is embryonically lethal in mice. Complete absence of fibronectin causes failure of mesoderm and neural tube formation, demonstrating that fibronectin-mediated cell adhesion is required for the most basic tissue organization during development.
These genetic "experiments" confirm that fibronectin and laminin are not merely structural filler. They are active participants in cell signaling, tissue organization, and organ function. Their peptide fragments carry biological information that cells use to make decisions about adhesion, migration, proliferation, and differentiation.
The study of how BPC-157 affects fibroblasts and collagen synthesis intersects with fibronectin biology: BPC-157's wound healing effects in animal models may involve upregulation of fibronectin expression at injury sites, though this mechanism is not conclusively established in human tissue.
The Bottom Line
Fibronectin and laminin are the two major non-collagenous glycoproteins that organize tissue architecture by connecting cells to the extracellular matrix. Fibronectin bridges fibroblasts and other cells to the collagen scaffold through integrin-RGD binding, while laminin forms the structural backbone of basement membranes through self-polymerization and integrin interactions. Their peptide fragments, particularly RGD, YIGSR, and IKVAV, have become essential tools in tissue engineering and wound healing research, and their matrikine biology underpins much of the cosmetic signal peptide category. The evidence base is strongest for RGD-functionalized biomaterials and weakest for topical cosmetic applications claiming fibronectin or laminin upregulation.